Convalescent Plasma as Treatment for COVID-19
All 6 patients who received treatment with convalescent plasma subsequently tested negative for SARS-CoV-2.
All 6 patients who received treatment with convalescent plasma subsequently tested negative for SARS-CoV-2.
Interleukin 17 may be a therapeutic target worth investigating for patients with lung cancer and SARS-CoV-2 infection, existing literature suggests.
Human trials on an experimental COVID-19 vaccine began in the United States on Monday, Pfizer and the German pharmaceutical company BioNTech said.
A novel rifabutin-based triple therapy (RHB-105) is effective for eradication of Helicobacter pylori, with eradication rates unaffected by resistance to clarithromycin or metronidazole.
For patients hospitalized with COVID-19, systematic anticoagulation (AC) may be associated with improved outcomes.
While no specific treatment for coronavirus disease 2019 (COVID-19) is currently available, several therapies are being investigated globally.
Progression in characterizing the symptoms and treatments for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent development of coronavirus disease 2019 (COVID-19).
Investigators addressed the possibility of an ethical dilemma for rheumatologists in the event there is a hydroxychloroquine shortage during the COVID-19 pandemic.
The FDA has launched a new webpage with information for recovered individuals who were infected with coronavirus disease 2019 (COVID-19) on where they can go to donate plasma to aid in the treatment of severely ill patients.
The use of probiotics as either an oral or topical treatment adjunct therapy may help in the management of acne vulgaris.